Fannin Innovation Studio Accepted Into NIDA's Medications Discovery Program

Houston, TX (PRWEB) October 03, 2022 -- Fannin Innovation Studio, an early-stage biomedical development and commercialization company, announces that the

Related Keywords

Corey Hopkins ,University Of Nebraska Medical Center ,Department Of Pharmaceutical Sciences College Pharmacy ,National Institutes Of Health ,Addiction Treatment Discovery Program ,Division Of Therapeutics ,National Institute Of Drug Abuse ,Innovation Studio ,National Institute ,Drug Abuse ,National Institutes ,Medical Consequences ,Atul Varadhachary ,Managing Partner ,Professor Corey Hopkins ,Pharmaceutical Sciences ,Nebraska Medical Center ,Managing Director ,Dev Chatterjee ,Fannin Innovation Studio ,Fannin Founded Entities ,Press Release ,